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Last August tiny cells in Petri dishes capti-vated primetime television audiences.In a carefully worded address, US Presi-
dent George Bush discussed the medical
potential, risks and ethics of studying human
embryonic stem (ES) cells. For proponents,
these cells represent our greatest hope for
treating devastating disorders such as Par-
kinson’s disease, diabetes and spinal-cord
injuries. But for those who are adamantly
opposed to the use of cells derived from
human embryos, stem cells from adults have
been advocated as an ethically palatable and
experimentally reasonable alternative.
Two papers in this issue rekindle the
debate. On page 50, Kim and colleagues1
describe how they generated a specific class
of neurons from cultured mouse ES cells and
used the neurons to reverse symptoms of
Parkinson’s disease in rats. In other words,
ES cells can generate specialized cell types
that are therapeutically effective in animals.
Meanwhile, Jiang and colleagues2 (page 41)
have derived remarkably versatile cells from
the bone marrow of adult mice, rats and
humans. These two studies further the
promise of stem cells even while they stoke
the debate about whether such cells should
be obtained from embryos or adults.
Stem cells, essential building blocks of
multicellular organisms, have two defining
properties — they can produce more stem
cells and they can generate specialized cell
types such as nerve, blood or liver cells. Stem
cells come in different varieties, relating to
when and where they are produced during
development, and how versatile they are.
Pluripotent stem cells give rise to all cell
types. The best characterized are ES cells
(Fig. 1), which are derived from very early
mouse or human embryos. These cells
proliferate indefinitely in culture, while
retaining the potential to differentiate into
virtually any cell type when coaxed. So, in
principle, ES cells might be able to generate
large quantities of any desired cell for trans-
plantation into patients.
Stem cells collected from tissues of adults
or older embryos are typically more restric-
ted in their developmental potential and
ability to proliferate. For example, blood-
forming (haematopoietic) stem cells make
all types of blood cells in vivo, but proliferate 
little in culture and have been thought not
to make cells of other tissues. Recent studies
have raised the possibility that some adult
stem cells can give rise to cells outside their
tissue of origin; however, these results are
controversial3 and have often proved difficult
to reproduce4. Nonetheless, those opposed
to using human ES cells tout the possibility
of pluripotent adult stem cells as a way of
realizing medical gain without ethical pain.
Although researchers generate ES cells from
pre-implantation embryos in culture, and
several countries have sanctioned deriving
human ES-cell lines from ‘surplus’ embryos
created through in vitro fertilization, some
remain uncomfortable with the destruction
of human embryos, even those destined
never to be implanted in a uterus.
Beyond these ethical issues, there are
technical obstacles to the use of ES cells. First,
these cells can be obtained only from very
early embryos and, although several human
ES-cell lines have been made, they will not
be immunologically compatible with most
patients who require cell transplants. So
researchers will need either to derive many
more ES-cell lines or to customize ES cells on
a patient-by-patient basis by ‘therapeutic
cloning’. Second, undifferentiated ES cells
form teratomas — benign tumours contain-
ing a mixture of tissue types — after being
transplanted. Thus ES cells must be reliably
differentiated into the appropriate cell type
in culture before transplantation.
Moreover, until now it had not been
proved that specialized cells derived from
cultured ES cells can actually function within
tissues after transplantation5,6. For example,
mouse ES cells produce insulin-secreting
cells in culture, but such cells have not been
shown to reverse high blood sugar levels in
mice with symptoms of diabetes6. It is per-
haps not surprising that cells generated in
vitro might not be equivalent to those arising
in vivo, given the extensive cellular interac-
tions and ‘education’ that take place during
development. But Kim et al.1 have now over-
come this problem in their work on rats with
symptoms of human Parkinson’s disease.
Parkinson’s disease is caused by the death
of neurons, found in the striatal region of the
brain, that produce the neurotransmitter
dopamine and are involved in controlling
movements. The symptoms of Parkinson’s
disease have been successfully treated in ani-
mals by transplanting dopamine-producing
neurons into the striatum to replace lost neu-
rons. In humans, however, results have been
mixed7. A central problem has been the
scarcity of suitable neurons. These neurons
would be abundant if they could be produced
from cultured ES cells, but this has proved
inefficient and it has been uncertain whether
the resulting neurons would be effective.
Enter Kim et al.1. To enhance the yield of
dopamine-producing neurons, the authors
expressed the Nurr1 protein — which is need-
ed to generate these neurons in vivo — in cul-
tured ES cells. The resulting neurons survived
NATURE | VOL 418 | 4 JULY 2002 | www.nature.com/nature 25
news and views
Stem-cell competition
Stuart H. Orkin and Sean J. Morrison













The debate continues over the relative merits of using embryonic and adult
stem cells for research — and perhaps, one day, to treat patients. Two new
papers look at the abilities of these remarkable cells.
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after being transplanted into rats with symp-
toms of Parkinson’s disease, and showed
appropriate electrophysiological properties.
More impressively, the rats started to recover
normal movements. Others have transplan-
ted partly differentiated ES cells to ameliorate
Parkinson’s symptoms in rats, but observed
tumours in some of the animals8. By demon-
strating efficacy while avoiding tumour
formation, Kim et al. have achieved a proof of
principle, although ES cells that have been
genetically modified in this way might not be
desirable for use in people.
To sidestep the disadvantages of ES cells,
it would be ideal to identify a pluripotent
adult stem cell that proliferates indefinitely
in culture. This is just what Jiang et al.2 seem
to have done. Prior work9 indicated that
there is a population of stem cells in bone
marrow, known as mesenchymal stem cells,
that can form muscle, cartilage, bone and fat.
Taking a similar approach, Jiang et al.
started with non-haematopoietic bone mar-
row cells, cultured them, and isolated a pop-
ulation that they called multipotent adult
progenitor cells (MAPCs).
In culture, single mouse MAPCs prolifer-
ated indefinitely and differentiated into many
specialized cell types. Upon injection into
mouse blastocyst-stage embryos, individual
MAPCs contributed widely to developing
tissues. And when injected intravenously
into adult mice they gave rise to several blood
and epithelial cell types. These stunning
findings cannot readily be explained by
incorrect identification of the progeny of the
transplanted stem cells. But it remains possi-
ble that the MAPCs might have fused with
blastocyst cells10,11, explaining their versatil-
ity in that experiment.
Are MAPCs the adult equivalent of ES
cells? More data are needed, yet so far it
seems that there are both similarities and
important differences between these cells
(Fig. 2). What, then, are MAPCs? They might
be very rare pluripotent stem cells that per-
sist from the embryo into adult life. To prove
this it would be necessary to identify these
cells prospectively in vivo (rather than retro-
spectively in vitro) by the marker proteins
they express, and to purify them without an
intervening culture step. 
Alternatively, MAPCs might not actually
exist in vivo. The extended period of culture
might have triggered certain bone marrow
cells to regress to a more primitive state, just
as primordial germ cells — from which eggs
and sperm are produced — can be repro-
grammed in culture to acquire properties
like those of ES cells12,13. (In fact, ES cells do
not exist as such in embryos; they arise after
being cultured.) If so, we have much to learn
about how cells can be reprogrammed in cul-
ture.
MAPCs might prove useful in treating
diseases irrespective of their origin. But,
until they have been identified in vivo, it’s
premature to speculate that they might have
a natural role in repairing injured tissues.
Moreover, although MAPCs can generate
many specialized cell types, it remains to be
seen whether those cells function normally
and could be used to treat animals, as Kim et
al.1 used ES-cell-derived neurons. Such exper-
iments will now be a priority, given the possi-
bility of isolating MAPCs from the bone
marrow of any patient, and transplanting the
progeny of these cells back to the patient
without risk of rejection.
The potential benefits of treating diseases
by using specialized cells generated in vitro
are enormous. But much further work is
needed. Possible risks include the tendency
of ES cells to form teratomas, and the
unknown hazards of using cells — whether
ES cells or MAPCs — that have been cultured
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Figure 2 Comparison of embryonic stem (ES) cells, and the multipotent adult progenitor cells
(MAPCs) described by Jiang et al.2.  ES cells (and mouse MAPCs) need LIF for growth; other cultured
cells do not, so this seems to be a unique feature of pluripotent stem cells. The expression of Oct-4 in
ES cells correlates with their versatility; if MAPCs are similar to ES cells one might expect comparable
expression of Oct-4. Germ cells are eggs or sperm. Dosage compensation inactivates one
X chromosome in females, so that males (which have one X and one Y chromosome) and females
(XX) express X-chromosome genes to the same degree. Autotransplantation refers to the possibility
of taking stem cells from patients, deriving the required specialized cells, and transplanting them
back in the patients.
                        Property       ES cells           MAPCs
Origin Embryo Adult bone marrow
Growth potential Indefinite Indefinite
Differentiate into most cell types? Yes Yes
Require growth factor LIF? Yes Yes ( for mouse MAPCs)
Stability of chromosome integrity Reasonably stable High
Expression of marker protein Oct-4 High Very low
Contribute to germ cells? Yes Not known
Produce blood cells on transplantation? No Yes
Display dosage compensation? No Not known
Efficiency of gene modification High Not known
Possibility of autotransplantation? No Yes
100 YEARS AGO
Mr. Marconi’s Results in Day and Night
Wireless Telegraphy. I can assure 
Prof. Joly that his explanation will not do.
The observed effect, which if confirmed is
very interesting, seems to me to be due to
the conductivity, and consequent partial
opacity, of air, under the influence of 
ultra-violet solar radiation. No doubt
electrons must be given off from matter
(dust as well as other matter) in the solar
beams; and the presence of these will
convert the atmosphere into a feeble
conductor. Conducting power in the sea-
water surface assists and guides the
waves, retaining them in two dimensions
after the same fashion as a telegraph wire
retains them in one; but conductivity in the
dielectric itself will tend to dissipate and
enfeeble the waves, by a process of
reflection resulting in some amount of
distortion. O. Lodge
From Nature 3 July 1902.
50 YEARS AGO
During the past three years, experiments
have been conducted with subjects who
have been given the task of solving 
mental-test items of a particular type.
Suppose PC be the probability that a
particular subject will continue to work
at a particular problem for some time t
before giving it up, and let PE be the
probability that if a solution is recorded
within this time it will be the correct one.
If the universe of discourse is now
restricted to correctly solved items, 
the probability (PS) that a particular 
correct solution will be returned within a
period of t sec. after the moment the
problem is presented will be a function 
both of the dynamics of the problem-
solving process as such and also of PC ….
Let PS be defined as the probability 
which would obtain if PC41 for t4`.
No comprehensive statement can be 
made about a person’s ability to solve a
problem which does not involve at least
these three probabilities, that is, any
attempt to measure ‘intelligence’ by
mental-test methods should involve
assessments of PC , PE and PS…. D is
the difficulty of the problem being 
considered, defined in the conventional 
but arbitrary fashion D4[1001R ], and 
R is the percentage of an adult British
population (unselected) who achieve
success with the item.
From Nature 5 July 1952.
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for long periods. And, although MAPCs
seem to have normal chromosomes, it is
important to establish that the pathways
governing cell proliferation are unper-
turbed. Otherwise, short-term gains might
fall prey to long-term complications.
The work of Kim et al.1 and Jiang et al.2
will not resolve the debate over embryonic
versus adult stem cells. Rather, it under-
scores the need for research in this area to
continue unfettered by political concerns.
Only then will the public have a chance to get
what it deserves: novel, validated and safe
treatments for intractable diseases. ■
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narrow intervals of elevation from a global
gridded data set, the group catalogued all
roughly circular, localized depressions. They
identified such depressions as candidate
impact features if concentric segments of
contours collectively totalled at least 1807 of
arc, and if the preserved relief exceeded 50 m
— a figure much larger than the altimetry
accuracy1 of about a metre. Many of the 
features so catalogued had been identified
as impact craters from orbiter images. As
shown in Fig. 1, however, many others had
not. In particular, Frey et al. counted 644
potential impact features greater than 50 km
in diameter in the northern lowlands, many
more than the 90 such features discernible
from Viking Orbiter images. A strong argu-
ment that most, if not all, of the newly identi-
fied features are largely buried impact craters
is that their areal density as a function of their
diameter has the same form as the distribu-
tion for known impact structures. The
southern highlands also contain buried
impact craters newly recognized by this
method, but they do not increase the total
population of impact structures by as large a
factor as in the north.
Frey and colleagues’ main conclusion is
that the geologically younger units constitut-
ing the uppermost crust of the northern
hemisphere are a relatively thin veneer of
material that incompletely masks an under-
lying ancient surface. There were a few
previous clues that this was so. Careful photo-
geological mapping led to the suggestion3
that underlying the deposits in the Utopia
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Asurprising finding from the explo-ration of Mars by orbiting spacecraft inthe 1970s was that the southern and
northern hemispheres have very different
surfaces. The density of impact craters seen
in images taken by Mariner 9 and Viking
Orbiter indicated that the surface of the
topographically high southern hemisphere
is old enough to have preserved the effects of
the early, heavy impact bombardment of the
inner Solar System (known from lunar stud-
ies to have occurred before about 3.7 billion
years ago). The surface of the northern hemi-
sphere, in contrast, was revealed to be gener-
ally lower in elevation, to consist of smooth
plains, and to contain a far lower density of
impact features — implying a surface age
hundreds of millions to billions of years
younger.
A new view of this striking hemispherical
contrast, the Martian ‘crustal dichotomy’,
has come from an analysis of observations
collected by the Mars Global Surveyor space-
craft, which has been in Martian orbit since
1997. From subtle signatures in topography
measured by the Mars Orbiter Laser Altime-
ter Experiment1, Frey and others2 have iden-
tified a large population of nearly buried
impact structures in both hemispheres that
were not evident in the spacecraft images.
More importantly, the areal density of these
features, together with those previously
mapped, indicates that the northern hemi-
sphere has a buried surface that is essentially
as old as the surface of the southern uplands.
Planetary science
An older face for Mars
Sean C. Solomon
Mars has a north–south divide in the age of its surface, as judged by the
density of impact craters. Altimetry data, which by inference provide a
subsurface view of the planet, reveal that the divide is only skin deep.
Figure 1 Partly buried impact craters, identified by Frey et al.2, in the northern lowlands of Mars.
The part of the planet shown is near the Utopia region. Elevation is colour-coded, with purple
grading through blue and green to yellow, orange and red as height increases (orthographic
projection, 50-m contour interval). Craters greater than 15 km in diameter visible in the earlier
Viking Orbiter images are circled by solid lines. The many more craters discernible only from their
topographic signatures are shown by thick dashed lines; thinner dashed lines denote less confident
identifications.
Frey and colleagues2 took the following
approach in their search for buried impact
features. From regional altimetric maps, in

















© 2002 Nature Publishing Group
